Is Summit Therapeutics a Millionaire Maker? [Yahoo! Finance]
Summit Therapeutics Inc. (SMMT)
Last summit therapeutics inc. earnings: 6/12 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
summitplc.com/investors/investor-centre
Company Research
Source: Yahoo! Finance
Big pharmaceutical companies start small, and then a blockbuster product catapults them into the spotlight. Summit Therapeutics (NASDAQ: SMMT) has soared 1,000% over the past year on progress in developing a drug that could rival Merck 's Keytruda, a product used to treat various cancers with over $25 billion in sales last year. Those who got in early have gotten rich. Is Summit Therapeutics still a potential millionaire maker? Or have investors gotten too far ahead of themselves? This promising oncology drug could be a big deal Summit Therapeutics is a biopharmaceutical company developing oncology drugs to treat various cancers. The company has not yet had any sales of its products. Its first potential drug, ivonescimab, is in phase 3 clinical testing. Ivonescimab works similarly to Merck's pembrolizumab by making cancer cells more vulnerable to the body's natural immune defenses and chemical treatments like chemotherapy. Summit is collaborating with another biopharmaceutic
Show less
Read more
Impact Snapshot
Event Time:
SMMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SMMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SMMT alerts
High impacting Summit Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
SMMT
News
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- 2024 COO of the Year Awards - Winners Announced [Yahoo! Finance]Yahoo! Finance
- Is Summit Therapeutics a Millionaire Maker? [Yahoo! Finance]Yahoo! Finance
- Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock? [Yahoo! Finance]Yahoo! Finance
- A Memoir Of Extraordinary Resilience: The Unstoppable Power Of Love, Science, And Community To Defy The Odds [Forbes]Forbes
SMMT
Earnings
- 10/30/24 - Beat
SMMT
Sec Filings
- 1/24/25 - Form 8-K
- 1/14/25 - Form 4
- 1/13/25 - Form 8-K
- SMMT's page on the SEC website